Bipolar disorder with comorbid anxiety disorders: Impact of comorbidity on treatment outcome in cognitive-behavioral therapy and psychoeducation

International Journal of Bipolar Disorders

Volumn 1, Issue 1, 2013, Pages 1-6

  Hawke, Lisa D ^a,d   Velyvis, Vytas ^b,c   Parikh, Sagar V ^d,e  

^a University Saint Boniface   (Canada)

^b YORK UNIVERSITY   (Canada)

^c Adler International Learning   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anxiety disorders; Bipolar disorder; Cognitive behavioral therapy; Comorbidity; Psychoeducation

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; COGNITIVE THERAPY; COMORBIDITY; COPING BEHAVIOR; DEPRESSION; EVALUATION AND FOLLOW UP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MEDICATION COMPLIANCE; MENTAL HEALTH; MOOD DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHOEDUCATION; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TREATMENT OUTCOME;

EID: 85015535185     PISSN: None     EISSN: 21947511     Source Type: Journal    
DOI: 10.1186/2194-7511-1-15     Document Type: Article

References (36)

1. Altman EG, Hedeker DR, Janicak PG, Peterson JL, Davis JM. The Clinician-Administered Rating Scale for Mania (CARS-M): development, reliability, and validity. Biol Psychiatry. 1994; 36(2):124-134.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision (DSM-IV-TR). Washington, DC: APA; 2001
3. Bauer MS, McBride L. Structured Group Psychotherapy for Bipolar Disorder: The Life Goals Program. 2nd ed. New York: Springer; 2003.
4. Bauer MS, Williford WO, Dawson EE, Akiskal HS, Altshuler L, Fye C, Gelenberg A, Glick H, Kinosian B, Sajatovic M. Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'Reducing the efficacy-effectiveness gap in bipolar disorder'. J Affect Disord. 2001; 67(1-3):61-78.
5. Benazzi F. Inter-episode mood lability in mood disorders: residual symptom or natural course of illness? Psychiatry Clin Neurosci. 2004; 58(5)480-486. doi:10.1111/j.1440-1819.2004.01289.x.
6. Bussing A, Matthiessen PF, Mundle G. Emotional and rational disease acceptance in patients with depression and alcohol addiction. Health Qual Life Outcomes. 2008; 6:4. doi:10.1186/1477-7525-6-4.
7. Coryell W, Solomon DA, Fiedorowicz JG, Endicott J, Schettler PJ, Judd LL Anxiety and outcome in bipolar disorder. Am J Psychiatry. 2009; 166(11):1238-1243. doi:10.1176/appi.ajp.2009.09020218.
8. Dusser I, Romo L, Leboyer M. Élaboration et évaluation d'un programme de gestion du stress pour patients souffrant de troubles bipolaires. J de Thérapie Comportementale et Cognitive. 2009; 19(2)56-60. doi:10.1016/j.jtcc.2009.08.002.
9. El-Mallakh RS, Hollifield M. Comorbid anxiety in bipolar disorder alters treatment and prognosis. Psychiatr Q. 2008; 79(2):139-150 doi:10.1007/s11126-008-9071-5.
10. Feske U, Frank E, Mallinger AG, Houck PR, Fagiolini A, Shear MK, Grochocinski VJ, Kupfer DJ. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry. 2000; 157(6):956-962
11. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. New York: Biometrics Research, New York State Psychiatric Institute; 2002.
12. Freeman MP, Freeman SA, McElroy SL The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord. 2002; 68(1):1-23
13. Glazer WM, Aaronson HS, Prusoff BA, Williams DH. Assessment of social adjustment in chronic ambulatory schizophrenics. J Nerv Ment Dis. 1980; 168(8)493-7
14. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6(4):278-296.
15. Hawke LD, Provencher MD, Parikh SV, Zagorski B. Comorbid anxiety disorders in Canadians with bipolar disorder: clinical characteristics and service use. Can J Psychiatr. 2013; 58(7):393-401
16. Keller MB. Prevalence and impact of comorbid anxiety and bipolar disorder. J Clin Psychiatry. 2006; 67(Suppl 1)5-7.
17. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC. The Longitudinal Interval Follow-up Evaluation. Comprehensive method for assessing outcome in prospective longitudinal studies. AArch Gen Psychiatry. 1987; 44(6)540-8
18. Lam DH, Jones S, Hayward P, Bright J. Cognitive Therapy for Bipolar Disorder: A Therapist's Guide to Concepts, Methods and Practice. New York: Wiley; 1999.
19. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007; 64(5)543-552. doi:10.1001/archpsyc.645.543.
20. Mueser KT, Rosenberg SD, Jankowski MK, Hamblen JL, Monica D. A cognitive-behavioral treatment program for posttraumatic stress disorder in persons with severe mental illness. Am J Psychiatr Rehabil. 2004; 7(2):107- 146. doi:10.1080/15487760490476183.
21. Norton PJ, Philipp LM. Transdiagnostic approaches to the treatment of anxiety disorders: a quantitative review. Psychother Theory Res Pract Train. 2008; 45(2):214-226. doi:10.1037/0033-320445.2.214.
22. Otto MW, Reilly-Harrington N. Cognitive-behavioral therapy for the management of bipolar disorder. In: Hofmann SG, Tompson MC, editors Treating Chronic and Severe Mental Disorders: A Handbook of Empirically Supported Interventions. New York: Guilford; 2002: p. 116-130
23. Otto MW, Simon NM, Wisniewski SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, Frank E, Nierenberg AA, Marangell LB, Sagduyu K, Weiss RD, Miyahara S, Thas ME, Sachs GS, Pollack MH. STEP-BD Investigators. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006; 189(1)20-25
24. Parikh SV, Zaretsky A, Beaulieu S, Yatham LN, Young LT, Patelis-Siotis I, MacQueen GM, Levitt A, Arenovich T, Cervantes P, Velyvis V, Kennedy S, Streiner DL. A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety Treatments (CANMAT) study. J Clin Psychiat. 2012; 73(06):803-810
25. Paykel ES, Abbott R, Morriss R, Hayhurst H, Scott J. Sub-syndromal and syndromal symptoms in the longitudinal course of bipolar disorder. Br J Psychiatry. 2006; 189:118-123.
26. Perlis RH, Ostacher MJ, Miklowitz DJ, Hay A, Nierenberg AA, Thase ME, Sachs GS. Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study. J Clin Psychiatry. 2010; 71(3)296-303
27. Provencher MD, Guimond A-J, Hawke LD. Comorbid anxiety in bipolar spectrum disorders: A neglected research and treatment issue? J Affect Disord. 2012; 137(1):161-164. doi:10.1016/jjad.2011.12.001
28. Provencher MD, Hawke LD, Baruch P, Pouliot L Transfert d'un groupe psycho éducatif pour le trouble bipolaire en 1èreligne [Transfer of a psychoeducational group for bipolar disorder to first-line treatment]. In: Annual Convention of Société Québécoise pour la Recherche en Psychologie Quebec City, Canada; 2011a.
29. Provencher MD, Hawke LD, Thienot E. Psychotherapies for comorbid anxiety in bipolar spectrum disorders. J Affect Disord. 2011b; 133(3):371-380 doi:10.1016/j.jad.2010.10.040.
30. Schaffer A, Cairney J, Cheung A, Veldhuizen S, Levitt A. Community survey of bipolar disorder in Canada: lifetime prevalence and illness characteristics. Can J Psychiatr. 2006; 51(1):9-16.
31. Schaffer A, McIntosh D, Goldstein BI, Rector NA, McIntyre RS, Beaulieu S, Swinson R, Yatham LN. Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Ann Clin Psychiatry. 2012; 24(1):6-22.
32. Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, Abbott R, Hayhurst H. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry. 2006; 188:313-320 doi:10.1192/bjp.188.4.313.
33. Thienot E, Provencher MD, St-Amand J. Traitement du trouble d'anxiété généralisée chez des individus présentantun trouble bipolaire: un protocole à cas unique [Treatment of generalized anxiety disorder for patients with bipolar disorder: a single case experimental design]. J de Thérapie Comportementale et Cognitive. 2013; 23(1):9-16. doi:10.1016/j.jtcc.2012.11.003.
34. Weissman A, Beck AT. Assessing depressogenic attitudes: a validation study. Paper presented at the 51st Annual Meeting of the Eastern Psychological Association. April 1980. Hartford, USA; 1980: p. 751980
35. Williams JM, Alatiq Y, Crane C, Barnhofer T, Fennell MJ, Duggan DS, Hepburn S, Goodwin GM. Mindfulness-based Cognitive Therapy (MBCT) in bipolar disorder: preliminary evaluation of immediate effects on between-episode functioning. J Affect Disord. 2008; 107(1-3)275-279. doi:10.1016/j. jad.2007.08.022.
36. Wong G, Lam D. The development and validation of the coping inventory for prodromes of mania. J Affect Disord. 1999; 53(1)57-65. doi:10.1016/S0165-0327(98)00096-2.